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Abstract: Type I modular polyketide synthases (PKSs), responsible 
for the biosynthesis of many biologically active agents, possess a 
ketosynthase (KS) domain within each module to catalyze chain 
elongation. Acylation of the KS active site Cys residue is followed by 
transfer to malonyl-acyl carrier protein, yielding an extended β-
ketoacyl chain. To date, the precise contribution of KS selectivity in 
controlling product fidelity has been unclear. We submitted six KS 
domains from the trans-acyl transferase PKSs to a mass 
spectrometry-based elongation assay, and identified higher 
substrate selectivity in the elongating step than in preceding 
acylation. A close correspondence between observed KS selectivity 
and that predicted by phylogenetic analysis was seen. Our findings 
provide insights into the mechanism of KS selectivity in this 
important group of PKSs, can serve as guidance for engineering, 
and show that targeted mutagenesis can be used to expand the 
repertoire of acceptable substrates. 
Polyketide synthases (PKSs) are responsible for the production 
of a vast array of biologically active compounds[1]. All PKSs 
build-up polyketide products by a series of chain-elongation 
steps, and are classified into types based upon their architecture. 
Bacterial type I modular PKSs are large multi-domain enzyme 
complexes. Each module is dedicated to one round of chain 
elongation and subsequent processing of its particular 
intermediate. The array of modules has been likened to a 
production line, with intermediates passed along in sequence. 
Within a PKS module, a single cycle of biosynthetic chain 
elongation minimally requires the activity of an acyltransferase 
(AT), to supply a malonyl or related extender unit, a 
ketosynthase (KS) domain to catalyze a Claisen-type chain 
elongation between the extender and growing acyl chain, and an 
acyl carrier protein (ACP) domain to tether the intermediates to 
the PKS via a thioester link (Scheme 1a)[2]. Chain elongation can 
be followed by modification of the β-keto product by processing 
domains such as ketoreductases (KR), dehydratases (DH) and 
enoylreductases (ER)[3]. These molecular factories therefore 
offer the prospect of novel bioactive natural products through 
rational engineering strategies[4], but questions remain as to how 
‘acceptable’ intermediate are recognized by PKS domains. 
In ‘textbook‘ PKSs, such as that responsible for erythromycin 
biosynthesis, a 1:1 correspondence between PKS architecture 
and product structure usually occurs. This principle of co-
linearity has greatly assisted assignment of each product to its 
synthase[5]. PKSs that fall into this category are termed cis-AT 
PKSs, due to the presence of an integral AT domain within each 
module. The trans-AT PKSs are an architectural variant of type I 
synthases that utilize free-standing AT enzymes[6].They often 
incorporate non-canonical modules and novel enzymatic 
domains, which results in poor biosynthetic assignment of 
clusters using the co-linearity rules referred to above[7]. trans-AT 
systems constitute approximately 40% of all bacterial 
multimodular PKSs[8], and represent a major, but poorly 
characterized, enzyme class of high relevance for drug 
discovery. 
One proposed mechanism for the maintenance of polyketide 
structural integrity is based on substrate specificity of the KS 
domains. Previous work on the cis-AT PKSs responsible for the 
biosynthesis of erythromycin and its relatives, has revealed that 
unnatural substrates were able to acylate a KS domain, but no 
elongated product was observed to be released by a 
downstream thioesterase[9]. It was suggested that the 
intermediate ‘stalled’ on the KS domain. Clear evidence for a KS 
‘gatekeeper’ role has been found in the iterative cis-AT PKS 
which produces aureothin.[10]  In contrast, some 
chemobiosynthetic studies, where the PKS is fed a non-natural 
acyl starter unit, have successfully produced polyketide analogs, 
and attempts to engineer artificial fusions of modules from eight 
cis-AT PKSs resulted in competent enzymatic assemblies, 
indicating more relaxed KS substrate selectivity in these 
cases[11]. Recent work on pikromycin module 5 has provided 
new structural insights into the dynamics of the ACP domain 
within a module[12]. It showed that the KR domain undergoes a 
large conformational change upon acylation, and that the 
position of the ACP domain within the module is dependent 
upon the degree of processing of its acyl chain. This mechanism 
may contribute to PKS selectivity by preventing access of the 
incorrect substrate to the downstream KS. Thus, the precise role 
of KS domains, from cis-AT PKSs, in controlling product fidelity 
remains unclear. 
In trans-AT PKSs the situation is believed to be rather different. 
Here KS domains have been shown to be closely correlated, at 
the sequence level, with their predicted substrates[13]. 
Phylogenetic analysis gives rise to a series of KS clades, each 
linked to specific types of intermediate (e.g. β-keto, β-hydroxy, 
enoyl etc.). No such correlation was found for cis-AT PKSs. This 
approach provides improved functional prediction of trans-AT 
biosynthetic clusters when compared with co-linearity rules, 
suggesting that KS substrate selectivity is an important property 
of trans-AT PKSs. To test these predictions, previous work by us 
examined the initial acylation step of trans-AT KSs (Scheme 1a). 
Although some specificity was observed, the tolerance profile 
was not as well defined as the phylogenetic grouping might 
suggest[14]. We suspected that further selectivity might be 
afforded at the elongation step of the KS-catalyzed reaction, 
where the acyl chain is irreversibly transferred from the KS to 
ACP-bound malonate to form a new C-C bond. Currently no 
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conclusive data on the relative selectivity of these two steps 
exist for KSs from either cis- or trans-AT PKSs.   
To provide new insights into substrate selectivity exhibited 
during the elongation step of KS-catalyzed polyketide 
biosynthesis in trans-AT PKSs, 
a range of KS domains from 
the psymberin (Psy) and 
bacillaene (Bae) PKSs [15] were 
examined.  
Scheme 1. KS catalysis and 
predicted substrates of Psy and Bae 
KS domains. (a) The catalytic cycle of 
a KS domain. Acylation by  an 
upstream ACP loads the KS with an 
acyl intermediate, followed by 
elongation through a Claisen 
condensation between the acyl 
intermediate and a malonyl unit. In 
cis-AT PKSs the AT domain is integral 
to the PKS, whereas in trans-AT 
systems the activity is supplied by a 
free-standing AT domain. X 
represents optional domains. (b) & (c) 
Partial proposed biosynthetic 
schemes for psymberin (1) and 
bacillaene (2). KS, ketosynthase; KS0, 
non-elongating ketosynthase; KR, 
ketoreductase; DH, dehydratase; CR, 
crotonase (also known as enoyl-CoA 
dehydratase, ECH); O-MT, O-methyl 
transferase; C, NRPS condensation 
domain; A, NRPS adenylation; GNAT, 
acetyl-loading AT; and •, ACP 
domains. KS domains are numbered 
and those used in this study 
highlighted in red. 
A new mass spectrometry-based assay was developed to 
quantify ACP-bound elongated β-ketoacyl chains arising from 
incubation of free-standing malonyl-ACP with a pre-acylated KS 
domain (see Supporting Information for details). A productive 
KS-catalyzed reaction resulted in detection of β-ketoacyl-ACP. 
Quantification was made possible by the addition of an alkyl-
ACP standard at the end of the incubation. Using this assay, 
chain elongation catalyzed by PsyA KS1 was analyzed. The 
natural substrate for this KS is the acetyl chain, which it is 
predicted to convert to an acetoacetyl unit (Scheme 1b). 
Following incubation of acetylated PsyA KS1 with malonyl-ACP, 
tandem MS activation of the ACP-bound derivatives revealed 
the presence of elongated acetoacetyl-ACP, with an associated 
decrease in malonyl-ACP, by detection of the ejected 
phosphopantetheinyl (PPant) ions (Figure 1, Figure S5). PsyA 
KS1 is located in phylogenetic clade VI with other acetyl-
accepting KS domains  (Scheme 1b, Figure S14). Previous 
work has shown that functionally, PsyA KS1 is capable of 
accepting a range of substrates at the acylation stage[14a]. This 
was tentatively attributed to the lack of evolutionary pressure 
upon the domain to confer selectivity towards an acetyl unit, due 
to the presence of a highly specific upstream N-acetyl 
transferase (GNAT) loading domain[16]. A set of seven simple 
acyl-SNAC thioesters (3 - 9) were screened against Psy KS1 for 
elongation activity by first acylating the KS domain and 
incubating the product with malonyl-ACP, using the assay 
described. PsyA KS1 showed a clear preference towards 
elongation of the acetyl unit (3), with the longer carbon chains (4 
- 6) disfavored (Figure 2a, Figure S7-13). There was no 
observable elongation for the β-methyl substrate (7), despite 
initial acylation of the KS. In addition, no elongation was 
observed with oxazolyl and pyranyl substrates (8) and (9), which 
are moieties present in various PKS intermediates[17]. Overall, 
these results suggest that, not only does PsyA KS1 impose 
selectivity at the elongation step of its catalytic action, but that 
a) 
b) 
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the selectivity is in excellent agreement with sequence-based 
phylogenetic predictions (Figure S14)[13]. 
Figure 1. KS catalysed production of β-ketoacyl chains. MS/MS spectra of the 
activated 7+ PsyA ACP3 species following acetyl elongation reactions in the 
absence (a), and presence (b) of PsyA KS1. Production of the acetoacetyl-
ACP (PPant ion m/z 345.2) is only seen after incubation with the acetyl-KS 
domain. Internal standard (PPant ion m/z 318.2) was added after the 
elongation reaction at a final concentration of 10 µM. 
The non-elongating domain, PsyD KS30 (Scheme 1b), was 
employed as a control for these experiments since it lacks an 
essential active-site His residue required for decarboxylation of 
malonate[7], and was therefore expected to yield no elongated 
product. Incubation of malonyl-ACP with PsyD KS30 acylated 
with a range of acyl groups (3 - 9) generated no observable β-
ketoacyl products (10 - 16), despite effective acylation of the KS 
domain[14a].  
In contrast to PsyA KS1, BaeJ KS2 and BaeL KS5 are predicted 
to accept and elongate much longer acyl chains (Scheme 1c). 
In phylogenetic terms, BaeJ KS2 is located in clade V (Figure 
S14) with other similar KS domains predicted to accept either 
fully saturated or β,γ-olefinic, unbranched acyl chains. BaeL KS5 
is located in clade IX, and is also believed to accept unbranched 
intermediates (Scheme 1c, Figure S14). Acylation studies, 
carried out on BaeJ KS2 and BaeL KS5 by us previously[14a,17], 
indicated that unbranched acyl chains were clearly favored. 
Elongation assays conducted on BaeJ KS2 revealed a 
remarkably different substrate profile from that seen for PsyA 
KS1, with the longer acyl chains preferentially elongated to form 
their β-ketoacyl equivalents  (11 – 13) (Figure 2b). In contrast, 
the short acetyl chain was elongated only poorly by BaeJ KS2, 
to yield little of the acetoacetyl-ACP (10). 
The X-ray structure of BaeJ KS2, acylated with its natural 
substrate, shows that the entire 10-atom chain is accommodated 
within a relatively hydrophobic binding pocket[18]. Presumably, 
favorable interactions between longer carbon-chains and this 
pocket account for the observed substrate preference of BaeJ 
KS2. A similar elongation profile was produced by BaeL KS5, 
with clear preference towards longer unbranched acyl chains 
(Figure 2c). In agreement with previous acylation data, no 
elongation was observed for a β-Me substrate (7), as evidenced 
by the absence of (14). Additionally, the oxazolyl and pyranyl 
substrates (8) and (9) yielded no elongated product. Overall, 
these data demonstrated that both BaeJ KS2 and BaeL KS5 
possessed a preference for substrates bearing longer acyl 
chains, and that both KSs were unable to catalyze elongation of 
β-branched chains, as predicted by phylogenetic analysis.  
Previously we have shown that an active-site mutant of BaeL 
KS5(M237A) was, in contrast to the wild type (WT), able to 
accept a β-methyl branched acyl chain at the acylation stage[14a]. 
Whether this KS variant had the ability to process the bulkier 
substrate fully, yielding elongated product (14), remained an 
open question. The elongation profile of BaeL KS5(M237A) 
revealed a similar trend to that of WT BaeL KS5 with regard to 
the straight chain acyl units, and preferential elongation of longer 
acyl chains was observed. However, the mutant was also found 
to be competent to elongate the β-methyl branched chain, as 
evidenced by the detection of β-ketoacyl-ACP (14) in the assay 
(Figure 2d). This suggested that the single MetAla point 
mutation in the active site of KS5 not only permitted acylation by 
the β-methyl SNAC, but that it also allowed the elongation step 
to be catalyzed. Pleasingly, the bulky oxazolyl and pyranyl 
substrates (8) and (9) were also elongated by this KS variant. 
This functional modification of BaeL KS5 highlights the attractive 
possibility of creating engineered trans-AT PKSs harboring KS 
domains with ‘non-native’ selectivity profiles. 
BaeJ KS1 (Scheme 1c) was also submitted to the elongation 
assay. Phylogenetically, BaeJ KS1 is located in clade XVI 
(Figure S14) and must accept and elongate 2-amidoacetyl 
intermediates. The elongation profile of BaeJ KS1 revealed 
categorical preference towards 2-amidoacetyl substrates, as 
evidenced by the elongation of (17) and (18), with preference 
shown towards the glycine substrate. There was no observable 
elongated product for any acyl chains which did not contain the 
2-amidoacetyl functionality (3 - 6) (Table S1).  
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Figure 2. Elongation-based substrate selectivity profiles of KS domains. 
Elongation selectivity profiles for Psy and Bae KS domains measured by the 
generation of β-ketoacyl products (10-16). 
The elongation assay performed on PsyA KS1 demonstrated a 
clear preference for the natural acetyl substrate over longer acyl 
chains contrasting with the rather broad substrate profile in the 
acylation step[14a], as described previously. To investigate 
whether the apparent lack of selectivity during acylation was due 
to the use of simple SNAC substrate analogues used, in an 
artificially bimolecular reaction, we cloned the PsyA apo-ACP1-
KS1 di-domain to provide an accurate representation of 
intramolecular ACP-KS transfer. When the ACP was loaded with 
either acetyl- or butyryl-PPant chains, from the corresponding 
Coenzyme A, this construct showed similar transfer of the two 
acyl groups from ACP1 to KS1 (see Figs S16 and S17 and 
Supporting Information for details of controls). This result shows 
that the selectivity of KS acylation, even within a native di-
domain, is lower than the subsequent elongation step.  
Our findings that KS substrate selectivity at the second 
elongation step exceeds that of acyl loading highlight the 
potential problem of KS enzymatic stalling. In order to restore 
enzymatic activity either the acyl chain must hydrolyze off the 
active site Cys, or the upstream ACP must deacylate the KS in a 
reversal of the initial acylation step. Once on the upstream ACP, 
the acyl chain may be removed from the ACP, possibly 
catalyzed by an acyl hydrolase (AH), or by cleavage at the β–
position, as seen in the mupirocin system[19]. In theory, both 
mechanisms are plausible, but we are unaware of any clear 
evidence in the literature for reversibility of the KS acylation step 
in a ‘stalled’ situation. In order to test the ability of the upstream 
ACP domain to deacylate the KS active site the ACP1-KS1 
didomain was again utilized. The KS1 active site Cys residue 
was acetylated prior to loading the PPant chain onto the apo-
ACP1 domain (Figure S19). Intramolecular transfer of the acetyl 
chain from the KS1 domain to the PPant chain of ACP1 was 
detected by MS/MS analysis as shown in Figure S21, 
demonstrating the inherent reversibility of ACP↔KS acyl 
transfer (Scheme 1a). Control measurements ruled out other 
sources of PPant acylation (see Supplementary for details).      
During polyketide biosynthesis, the maintenance of product 
fidelity requires a mechanism for intermodular transfer of the 
correct intermediate and in trans-AT PKSs the hypothesis that 
KS domains fulfil a ‘gatekeeper’ role has been proposed[17,19]. In 
principle, KS selectivity could be manifest at the initial acylation 
step, at the C-C forming elongation step, or both. Our previous 
work, based on examining substrate tolerance during the KS 
acylation step, has shown that some selectivity does exist. 
However, the selectivity is not as strictly defined as phylogenetic 
analysis would predict and here we show that a high level of 
selectivity is observed during the KS-catalyzed elongation step, 
in line with that predicted phylogenetically. Moreover, by using 
the PsyA ACP1-KS1 didomain we confirm that relatively low 
selectivity is exhibited at the acylation step, even for a tethered 
substrate. Thioester bonds are high energy linkages, which form 
and break rapidly in the presence of a thiol, or thiolate, by a 
process of transthioesterification[21]. Thus, acyl transfer between 
an ACP and the immediate downstream KS may be difficult to 
control, leading to relatively limited enzymatic selectivity, and a 
potentially reversible process. Indeed, it has been observed that 
a large excess of SNAC thiol is able to remove an acyl group 
from the KS active site by transthioesterification[22].  
 
The differential selectivity observed in KS acylation and 
elongation steps does raise a potential problem: namely non-
productive acylation of the enzyme’s active site by a substrate 
incapable of being elongated. Providing that KS acylation is 
reversible, however, this problem can be overcome, since the 
acyl chain can be transferred back to the upstream module. The 
rate constant for back transfer from KS to upstream ACP has 
been measured for the cis-AT DEBS module 2 and found to be 
very low, leading to the conclusion that acylation is practically 
irreversible36. It should be borne in mind, however, that these 
observations were made for a productive substrate under steady 
state conditions, and not for a stalled substrate incapable of 
elongation. Our findings using PsyA ACP1-KS1 demonstrate 
that KS acylation in this trans-AT PKS didomain is a reversible 
process (in the absence of a downstream malonyl-ACP), and 
that this mechanism may allow unloading of non-productive 
substrates from the KS domain. 
In summary, we have shown that five KS domains from the 
trans-AT PKSs responsible for the biosynthesis of psymberin 
and bacillaene exhibit substrate preference that is in agreement 
with that predicted by phylogenetic analysis of their sequences. 
These findings provide functional testing of the proposal that KS 
domains from trans-AT PKSs do possess selectivity for their 
intermediate. Moreover, we also show that this selectivity can be 
modulated by rational enzyme modification.        
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